Pediatric procedural sedation and analgesia in the emergency setting in community hospitals in Italy: current status and challenges Authors: Martina Langeli, Flavia Predieri, Michele Di Toma, Angelo Campanozzi, Simone Rugolotto, Francesco Torcetta, Alessandro Mazza, Tiziana Zangardi, Marco Bazo, Carla Pizzini, Silvia Bressan Published: 2025 ABSTRACT AbstractBackgroundWe investigated the use of mild procedural sedation/analgesia in children at community hospitals to describe current practices and identify challenges to its effective implementation.MethodsCross-sectional survey among all medical and nursing staff of the Paediatric, Emergency, Anesthesiology and Surgical Units of four secondary care hospitals in Italy, in the years 2021–2022.ResultsThe response rate was 80% (range across centers 57%-100%); 346 complete questionnaires were analyzed (52.6% physicians; 47.4% nurses). Overall, procedural pain in children was considered a relevant topic by 90.8% of staff. Procedural sedation/analgesia was considered helpful for procedural success (97.4%) and for improving children’s experience of pain/anxiety (98.6%). However, 47.7% were not satisfied with the management of procedural pain/anxiety at their workplace and 56.9% reported a lack of adequate knowledge. In fact, only 22.8% demonstrated adequate knowledge on fasting times and 39.6% on correct patient monitoring during procedural sedation. From a pharmacological perspective, midazolam was the most accessible (80.9%) and used (58.7%) medication, while intranasal fentanyl and nitrous oxide were less available (15.3% and 2.9% respectively) and used (7.2% and 2.6% respectively). Procedural sedation was generally practiced by anesthesiologists (65.9%). Overall, 91.9% of respondents performed/participated in < 4 pediatric sedations per month. For 64.3% lack of training represented the greatest barrier to pediatric sedation/analgesia implementation.ConclusionsDespite staff awareness about the importance of pediatric procedural sedation/analgesia, lack of specific knowledge and training, as well as limited availability of sedative/analgesic medications represent current challenges to procedural sedation implementation in community hospitals without a pediatric emergency room.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13052-025-02173-7.Keywords: Analgesia, Children, Emergency department, Nitrous oxide, Midazolam, Fentanyl Background Pain and injuries are common reasons for presentation to the emergency department (ED), especially in children, representing up to 60–70% of pediatric ED visits [1]. According to the revisited definition of pain, “a distressing sensory and emotional experience with actual or potential tissue injury”, pain is always a subjective symptom, potentially associated with a psychological component. It is not only nociception and verbal description, but it is one of several ways to express suffering, particularly in children [2]. Pain in the emergency setting is often associated with fear and anxiety not only for the discomfort related to pain itself, but first and foremost for the unexpected hospital encounter and the need for unknown and, often painful, procedures [3]. Effective and prompt analgesia, anxiolysis and sedation (collectively referred to as procedural sedation and analgesia, PSA) outside the operating room have become the standard of care for the management of pain and anxiety in children undergoing painful or anxiogenic diagnostic and therapeutic procedures. Despite the availability of many international guidelines for pediatric PSA since the early 2000s, in actual clinical practice, pain and anxiety often remain underrecognized and undertreated, especially in the emergency setting [4–7]. In Italy the PIPER (Pain In Pediatric Emergency Room) study group, which is involved in activities aimed at improving pain management in children, and other reports found that pediatric pain management is still suboptimal in EDs despite the availability of guidelines for the management of pediatric pain [8–10]. Recent studies have identified several barriers to the implementation of procedural sedation and analgesia (PSA), including the limited availability of certain medications, the absence of standardized protocols, staff shortages, and inadequate physical spaces. However, these studies primarily reflect the context of pediatric emergency departments in tertiary care centers and are largely based on responses from department heads or their delegates [8, 11]. Of notice, the state of Emergency services in Italy is very heterogeneous. Most children are taken care of in adult EDs, which often are not equipped with dedicated staff for pediatric emergency care, while pediatricians cover pediatric wards for 12–24 h; only about a third of children have access to third level care in pediatric EDs [8, 9]. Moreover, there is an uneven geographical distribution of facilities, with significant differences among Northern and Central Italy, as well as Northern and Southern Italy. For this reason, in certain community hospitals, or secondary care centers, it is not unusual for children to be managed by healthcare professionals without specific pediatric skills. This is even more evident in the context of PSA, where specific recommendations on training requirements to acquire the necessary PSA skill set, have only recently been published [12]. To the best of our knowledge, no previous studies have exclusively surveyed the status of PSA in Italian secondary-level hospitals, targeting all healthcare professionals involved or potentially involved in this practice from both medical and nursing perspectives. Therefore, the objective of our study was to describe the current minimal-mild PSA practice patterns in Italian secondary level hospital facilities without a dedicated pediatric emergency room, highlighting barriers to best practices, with the ultimate goal of improving the care of children’s procedural pain and anxiety across all levels of care. Methods Study design, setting and study period A cross-sectional survey study was conducted in the years 2021–2022 through the administration of an online questionnaire to the medical and nursing staff of the Paediatric, Emergency, Intensive Care Units and Surgical wards belonging to four secondary-level Italian hospitals: Santa Maria della Misericordia in Rovigo, Policlinico Riuniti in Foggia, IRCCS Sacro Cuore in Negrar Valpolicella (Verona), and Ramazzini in Carpi (Modena). Study population The survey was distributed to the medical staff of the Emergency Room, Pediatrics, Anesthesia-Resuscitation, Pediatric Surgery, Orthopaedics, and Ear Nose and Throat wards, as well as to nursing staff of the Pediatric wards and Emergency Rooms. The sample included medical and nursing staff involved in procedural sedations in the emergency setting in hospitals without a pediatric emergency room. Survey The questionnaire was developed by a medical-nursing working group of experts in pediatric and pediatric emergency care, and it was reviewed and tested several times by the working group until a consensus was reached on the content and form of each question. Content validity was achieved through expert consensus. The questionnaire development process included: establishment of the board, expansion of the panel of participants, web meetings to discuss the versions of the survey, drafting of the final survey. The questionnaire underwent pilot testing at Ramazzini Hospital, Carpi, where it was administered via QR code to pediatric physicians over a period of two weeks. Feedback was systematically collected to identify issues and gather suggestions aimed at improving the clarity, comprehensibility, and overall usability of the instrument to enhance face validity prior to its implementation in the main study. The questionnaire was composed of 37 questions, and it was structured into four sections as follows: demographic information (6 questions), personal perspectives and knowledge (16 questions), current pediatric PSA practice at the respondents’ workplace (10 questions), PSA related training (5 questions). The questionnaire was accessible online through the REDCap (Research Electronic Data Capture) [13, 14], via direct access links shared by email; furthermore, posters were created for its dissemination in the wards involved in the projects. Posters included a QRcode that participants could frame, directly linking to the questionnaire. The participation took place on a voluntary basis, respecting the general principle of anonymity. The full survey, translated in English, is reported in Additional File 1. Statistical analysis A descriptive analysis was carried out with calculation of frequencies and percentages for the categorical variables. Associations among variables were explored with the Chi-squared test. A p < 0.05 was considered statistically significant. The statistical software Jamovi was used. Results The response rate was 80%, with a range between 57% and 100% across participating centers. Three hundred and forty eight healthcare professionals completed the survey (47.4% nurses and 52.6% physicians). Overall, female respondents were 62.1%. The Emergency Room was the most represented (39.3% of responses), followed by Pediatric wards (27.2%) and Intensive Care Units (22.0%). Almost half of the healthcare professionals who responded to the survey (50.6%) usually took care of less than ten pediatric patients in one month and more than half (52.9%) declared that PSA was performed only by anesthetists. While 49.1% of the sample had not performed any PSA in the month preceding the survey, 42.8% had performed less than four PSA in the same period. Procedures for which PSA was most often used at the respondents workplace were wound suture (87.3%), difficult venous access (83.2%), burn dressing (75.1%), lumbar puncture (63.6%) and foreign body removal (60.1%). Characteristics of healthcare professionals who completed the survey are reported in Table 1. Table 1Characteristics of healthcare professionals that participated in the study and their setting of workQuestionAnswern°%What is your profession?Physician18252.60%Nurse16447.40%What ward do you work in?Pediatric Ward9427.20%Emergency Room13639.30%Intensive Care Unit7622.00%Surgery/Orthopedic/Urology/ENT (Ear Nose and3811.00%Throat) WardI prefer not to answer20.60%What gender do you identify with?Male12636.40%Female21562.10%I prefer not to answer51.40%How old are you?< 30 years old6819.70%30–40 years old12335.50%41–50 years old7622.00%51–60 years old5415.60%> 60 years old257.20%How many years of work experience do you have?< 510831.20%5–107822.50%11–206919.89%21–304212.10%> 304914.20%How many children have you taken care of in the last month in your clinical setting?< 1017550.60%10–5012235.30%51–1003911.30%> 100102.90%In your hospital, who carries out minimal/mild pediatric analgosedation? [Multiple choice]Anesthetist22865.90%Emergency room doctor5816.80%Consultant doctor who is not an anesthetist257.20%Team dedicated to procedural sedation and analgesia236.60%Nobody3811.00%I don’t know308.70%In your setting, how many minimal/mild PSA have you carried out outside the operating room, in children?None17049.10%< 4 per month14842.80%1–2 per week205.80%3–7 per week82.30%> 2 per day00.00% Characteristics of healthcare professionals that participated in the study and their setting of work With respect to personal perspectives and knowledge: 90.8% of healthcare professionals considered pain a relevant topic for their profession, 97.4% of the completed surveys revealed that PSA was considered important in order to improve the success of pediatric emergency procedures and to reduce anxiety and pain in pediatric patients (98.6%). Almost half of respondents (47.7%) were not satisfied with the management of anxiety and pain in pediatric emergency care at their institution, while most (68.8%) believed the treatment of pain and anxiety to be an ethical imperative and PSA to improve the care of pediatric patients (75.1%). A lower percentage considered PSA for children in the emergency setting as a safe option compared to the operating theatre or a standard of care (20.2% and 30.0% respectively). Most of the respondents correctly identified the definition of PSA (86.4%) and of minimal/mild PSA (80.0%). However, only 22.8% were aware of the correct recommendations about fasting time for minimal/mild PSA, while less than half (39.6%) provided a correct response on monitoring recommendation for minimal/mild PSA (Table 2). Table 2Fasting time and type of monitoring recommendedQuestionAnswern°%How much fasting time is recommended for procedures involving minimal/mild sedation?30 min236.6%1 h329.2%2 h15043.4%Not recommended7922.8%I don’t know6217.9%What type of monitoring is recommended in children undergoing minimal/mild sedation?The use of any monitoring, beyond clinical observation, is not recommended as long as verbal contact remains with the child, otherwise the use of pulse oximetry is recommended13739.6%Monitoring with pulse oximeter always14842.8%Monitoring with pulse oximeter and capnography always4212.1%I don’t know195.5% Fasting time and type of monitoring recommended With respect to knowledge on medications, 81.8% responded that Midazolam, either administered intranasally or orally was safe and effective, while this percentage decreased to 58.4% for intranasal Fentanyl, and to 43.4% for nitrous oxide premixed with oxygen. Of interest, 32.9% of healthcare professionals responded they did not know whether nitrous oxide was safe and effective. Perceived effectiveness and safety of nitrous oxide, fentanyl and midazolam are reported in Fig. 1(a). Risk of respiratory depression/need for ventilation after drug administration are represented in Fig. 1 (b). (A) Effectiveness and safety of nitrous oxide, fentanyl and midazolam. Survey assuming the use at the recommended dosage for minimal/mild sedation outside of the operating room. (B) Risk of respiratory depression/need for ventilation after administration of nitrous oxide, fentanyl and midazolam. Rare (< 1%), Infrequent (1–5%), Frequent (6–10%), Very frequent (> 10%) When analyzing the questions that tested the knowledge on medications side effects, the risk of respiratory depression using Midazolam intranasally or per os was rated as rare or infrequent by 74.6% of respondents, while the same response was provided by by 51.2% of respondents for intranasal fentanyl and by 48.0% for nitrous oxide. Lastly 33.5% of healthcare professionals declared that they did not know about the side effects of nitrous oxide. The chi-square test revealed that there is no statistically significant relationship between years of work experience and correct knowledge regarding mild/minimal sedation. Table 3. Table 3Correct PSA knowledge and work experience*ExperienceExperienceExperienceChi-square**p-value< 5 years≥ yearsKnowledge about recommended monitoringYes38 (27.9%)77 (36.7%)2.830.092No98 (72.1%)133 (63.3%)Knowledge about recommended fastingYes26 (19.1%)53 (25.2%)1.750.185No110 (80.9%)157 (74.8%)Risk of respiratory depression after oral/intranasal midazolamYes58 (42.6%)100 (47.6%)0.8220.364No78 (57.4%)110 (52.4%)Risk of respiratory depression after intranasal fentanylYes21 (15.5%)44 (21.0%)1.640.2No115 (84.5%)166 (79.0%)Risk of respiratory depression after premixed nitrous oxide with O2 (50% mixture)Yes38 (27.9%)46 (21.9%)1.640.201No98 (72.1%)164 (78.1%)Effectiveness and safety of midazolamYes61 (34.8%)93 (50.2%)0.01080.917No75 (65.2%)117 (49.8%)Effectiveness and safety of fentanylYes46 (44.8%)57 (27.1%)1.760.184No90 (55.2%)153 (72.9%)Effectiveness and safety of premixed nitrous oxide with O2 (50% mixture)Yes37 (27.2%)50 (23.8%)0.5060.477No99 (72.8%)160 (76.2%)* Experience: the experience was divided into two groups using as a discriminant the minimum possible level of experience investigated, i.e. less than 5 years of experience** based on Chi-square test Correct PSA knowledge and work experience * Experience: the experience was divided into two groups using as a discriminant the minimum possible level of experience investigated, i.e. less than 5 years of experience ** based on Chi-square test Concerning the use of non pharmacological techniques and PSA-related medications in the different work settings investigated, EMLA (lidocaine 2,5%, prilocaine 2,5%) was the most available (68.5%) and used (60.4%), and the only one present in more than a half of the facilities. Only the use of Midazolam either intranasally (28.9%) or orally (29.8%) was reported by more than a quarter of respondents, Fig. 2. Pharmacological and non-pharmacological techniques available and used at the respondents workplace Availability of PSA related tools and protocols was also investigated. The Mucosal Atomizing Device (MAD) for intranasal medication administration was available to 32.7% of respondents. Only 5.8% of professionals stated that approved protocols for PSA were available and used in their settings. The most frequent reason for unavailability or lack of use of PSA-related protocols was lack of training on pediatric PSA (64.3%), Table 4. Table 4PSA related tools and protocolsQuestionAnswern°%Is the MAD (Mucosal Atomization Device) for intranasal drug administration available in your clinical setting?Yes11332.7%No13719.8%I don’t know9613.9%In your clinical setting, are there approved and shared protocols/routes on minimal/mild procedural sedation and analgesia outside the operating room, for children?Yes, we use them205.8%Yes, but we don’t use them yet5014.5%No14842.8%I don’t know12837.0%If there are no protocols or if they are not yet used, why?Fear of adverse effects2213.0%Lack of training10864.3%Shortage of staff2615.5%Lack of time2716.1%Lack of dedicated spaces2112.5%Other31.8% PSA related tools and protocols With respect to training, 76.0% of healthcare professionals had never carried out a training course on the assessment and management of pediatric pain and anxiety and 88.7% had never participated in a PSA training course. Those who participated in a PSA course stated that they could not apply enough of what they had learned in their clinical context in approximately half of cases. Finally, 96.5% of the study population stated that receiving training in pediatric PSA was important for their profession, Table 5. Table 5PSA related trainingQuestionAnswern°%Have you ever participated in a training course on pain assessment and management in children?Yes8324.0%No26376.0%Have you ever participated in a training course on pediatric procedural sedation and analgesia?Yes3911.3%No30788.7%If yes, have you had the opportunity to apply what you learned in your clinical setting?Not at all37.7%A little1743.6%Somewhat1230.8%A lot410.3%Very much37.7%How important do you think it is to receive training in minimal/mild procedural sedation and analgesiaanalgosedation outside of the operating room for children in a pediatric setting?Not at all10.3%A little113.2%Somewhat5616.2%A lot12636.4%Very much15243.9% PSA related training Discussion Our study provides a multicenter snapshot on the provision of minimal-mild PSA to children in the emergency care setting in secondary-level community hospitals in Italy. Based on the high response rate, our survey ensured a good representativeness of the sample of interest at the four participating sites. Our findings highlight a substantial gap between awareness and implementation. Although most healthcare professionals acknowledge PSA as essential for reducing pain and anxiety in children, many—particularly non-pediatric staff—continue to perceive it as unsafe or risky. This gap has been previously described; according to Rephaeli et al. [15], although the majority of consultant surgeons acknowledged the importance of pediatric PSA in the ED setting, a high percentage would still perform painful procedures without PSA if it was not readily available. While the majority of respondents to our survey believed PSA to be important as a means to improve patient care and more than half considered PSA to relieve children’s pain and anxiety as an ethical imperative, less than 50% considered it a safe option, or a standard of care; this perception, combined with limited training opportunities, scarce availability of drugs and protocols, and organizational barriers, contributes to the persistent underuse of PSA outside tertiary centers despite the large available body of evidence in the field [16–20]. Overall, our data highlight a systemic need for structured education, institutional protocols, and adequate resources to ensure equitable pediatric care across all hospital levels. Bridging the gap between knowledge and practice is crucial to normalize PSA as a standard of care rather than an exception. This goald could be achieved by developing a true culture of procedural sedation that encompasses comprehensive patient management according to well-defined safety protocols, training, and skill maintenance. In a recent study, Leroy et al. focused specifically on the need to raise awareness on procedural sedation management by identifying a set of core competencies in the domains of knowledge, skills, and attitudes across physical safety, effectiveness, psychological safety, and deliberate practice [21]. Access to the medications needed to provide effective PSA is also a key aspect for effective PSA implementation. In our survey intranasal fentanyl and nitrous oxide were less available (15.3% and 2.9% respectively) and used (7.2% and 2.6% respectively) compared with midazolam. This finding considerably differs from other settings where these medications are widely used in pediatric emergency care for their high efficacy and safety profiles, even in combination, based on institutional protocols [20, 22–25]. Non-pharmacological techniques, along with all pharmacologic options required to provide minimal-to-mild sedation, should be available and routinely implemented across all levels of care [11]. Moreover, the Mucosal Atomization Device (MAD) for intranasal administration of fentanyl and midazolam should be readily accessible. In our study, however, only one third of respondents reported that the MAD was available in their clinical setting. Besides availability of medications and equipment for their administration, the efforts of minimal-mild PSA implementation should be mainly directed towards the training of non-anesthesiologist physicians and nurses. Over half of respondents stated that all PSA levels, including minimal-mild PSA, were exclusively performed by anesthesiologists in their setting. At a European level, a recent study showed that procedural sedation in children is predominantly performed by pediatricians, accounting for 82% of cases [22]. Indeed, most of the procedures that would benefit from minimal-mild PSA in children are routine frequent procedures, such as wound sutures, difficult venous accesses, minor burn dressings or lumbar punctures, which could not be handled by anesthesiologists given their high volume of work and the need to direct their skill set to the operating room, intensive care units or more complex patients or procedures requiring deeper levels of sedation and analgesia. Previous studies have highlighted how PSA is infrequently performed in children undergoing venipunctures, nasogastric tube placement, or bladder catheter placements and that most children needing sutures received local anesthetic injections instead of the LAT gel (lidocaine 4%, adrenaline 0.05%, tetracaine 0.5%) to provide effective local anaesthesia [26]. Effective training has the potential to greatly improve the care of children receiving these frequent painful procedures. The need for specific training clearly emerged from our survey, particularly from the section dedicated to training-related questions. Only one tenth of the respondents had completed a course on pediatric procedural sedation and analgesia (PSA), yet the vast majority recognized training as an essential prerequisite for safely providing PSA to children [22, 27–29]. However, a recent European survey has highlighted as most common barriers to the implementation of procedural sedation physician and nursing staff shortage, lack of physical space, of topical anesthesia for laceration care, and of general safety and monitoring guidelines [22]. Current consensus guidelines emphasize the need for structured and comprehensive training for healthcare professionals involved in procedural sedation [11, 30, 31]. Such training should encompass patient assessment, understanding of the pharmacology and physiology of sedative agents, mastery of the selected sedation techniques, appropriate use of monitoring systems, evaluation of recovery of normal functions, and recognition and management of potential complications. In addition, proficiency in airway management and competence in performing cardiopulmonary resuscitation are considered essential components of procedural sedation practice [11, 30, 31]. Furthermore, procedural sedation competencies should be reinforced through regular simulation-based training [31]. Recent studies have demonstrated the effectiveness of advanced training modalities such as high-fidelity simulation [32, 33] and virtual reality–based training [34]. These approaches have been shown to enhance knowledge acquisition and retention, improve both theoretical understanding and procedural performance, and facilitate the development of clinical competencies [32–34]. Although no single modality has yet been proven superior, virtual reality remains a promising and evolving educational approach. However, most available studies have focused on learners in training, while data involving practicing healthcare professionals are still limited [32–34]. Alongside training, another key element to ensure effective implementation of best practices is the availability of institution wide and shared protocols and procedures, which were lacking at the respondents’ workplace in the majority of cases. However, national and international guidance is available to facilitate the development of local documents to define roles, responsibilities and procedures at individual institutions and resources should be dedicated to the production of local protocols and guidelines [11, 16–20, 29]. Overall, our survey has identified the gaps in provision of minimal/mild PSA to children in community hospitals in the emergency care context, enabling planning of implementation strategies to ensure that the standards of care for children are met across all levels of care. The results of our study need to be interpreted in light of its limitations. As a matter of fact, the study’s generalizability is limited by several factors. First, the use of an ad-hoc non validated questionnaire. This is a significant weakness of our study. However, no validated questionnaire is available for this purpose. As described in the methods section, despite the lack of formal validation, expert development, review and pilot testing were performed in order to maximize the robustness and face validity of the data collection tool used in our study. In addition, despite being multicenter, the study was carried out in a small and geographycally unbalanced sample of four hospitals, connected by pediatric and nursing staff conducting their research projects at the University of Padova, Italy, as part of their nursing graduation or second-level short specialisation degree at the Department of Women’s and Children’s Health. This trait d’union across participating centers allowed for high standardization of study procedures and from the passionate commitment of staff coordinating the study at each institution, which was essential to achieve a high response rate. Finally, survey studies, by assessing the opinions of participants, may not accurately reflect what happens in actual clinical practice. However, given the consistency of responses across centers to several questions of the survey, it is unlikely that the results of our survey would substantially differ from reality. Despite this, our work effectively highlights key cultural and structural barriers that must be addressed to advance safe pediatric PSA practice in secondary-care hospitals with no pediatric emergency room. Conclusions Our survey revealed that although most healthcare professionals acknowledge PSA as essential for reducing pain and anxiety in children, many—particularly non-pediatric staff—continue to perceive it as unsafe or risky. This perception, compounded by limited training opportunities, restricted access to medications and standardized protocols, and organizational barriers, contributes to the ongoing underuse of PSA outside tertiary centers. These findings highlight a systemic need for structured education, institutional guidelines, and adequate resources to ensure equitable pediatric care across all hospital levels. Bridging the gap between knowledge and practice is crucial to establishing PSA as a standard component of care rather than an exception. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements This project was conducted as part of the second-level short specialisation degree in Pediatric Emergency Medicine held by the Department of Women’s and Children’s Health and nursing degree graduation projects at the University of Padova, Italy. This study could be achieved thanks to the substantial efforts of co-authors working at each participating hospital. Knowing individual hospitals’ own characteristics and key staff to involve for the purpose of this project was instrumental to its successful roll-out and overall conduct. The authors do acknowledge all the healthcare professionals from the Emergency Room, Pediatrics, Anesthesia-Resuscitation, Pediatric Surgery, Orthopaedics, and Ear Nose and Throat wards, who voluntarily completed the survey, as well as the Directors and the Head Nurses of these wards for their collaboration and support in facilitating its distribution and completion. Abbreviations Emergency Department Electroencephalogram Ear Nose and Throat Mucosal atomization device (Pain In Pediatric Emergency Room) study group Procedural sedation and analgesia Research Electronic Data Capture Author contributions SB, ML and FP conceptualized the study. All the authors contributed to the development of the survey. ML, FP, MDT and MB developed the data collection tool. ML and CP conducted data analysis. SB provided oversight of study procedures. ML, FP, CP and MDT drafted the manuscript. All the other authors critically reviewed and revised the manuscript. All authors had responsibility for the decision to submit the study for publication. Funding No sources of funding to declare. Data availability The datasets generated and analysed during the current study are available in Zenodo repository, at the link 10.5281/zenodo.15068730. Declarations Ethics approval and consent to participate Being a survey collecting anonymous data only, a waiver of approval from the Ethics Committee was granted and the study protocol was assessed and approved by the Internal Research Review Board within the Division of Pediatric Emergency Medicine of the Department of Women’s and Children’s Health, University Hospital of Padova and was conducted in accordance with the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Langeli Martina and Predieri Flavia : Joint first authors. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets generated and analysed during the current study are available in Zenodo repository, at the link 10.5281/zenodo.15068730.